VisionWave today announced that, together with its joint-venture partner Boca Jom, Ltd., it is completing a proof-of-concept (POC) release of AstraDRC™, a patented, automated Integrated Circuit (IC) ...
BELTSVILLE, Md. - NextCure, Inc. (NASDAQ:NXTC) announced Friday that data from its SIM0505 antibody drug conjugate Phase 1 dose escalation study is expected in the second quarter of 2026, while its ...
JACKSONVILLE — Misty Gardner, program manager for Big Brothers Big Sisters of Northeast Alabama, told members of the Exchange Club of Jacksonville at a recent meeting that mentoring can change the ...
TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...
(RTTNews) - Gilead Sciences (GILD) and Assembly Biosciences (ASMB) announced Gilead has exercised its combined option to exclusively license Assembly Bio's herpes simplex virus helicase-primase ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus ...
Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio’s herpes simplex virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results